A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial
Open accessThe DOI matches its Crossref record; 106 of the 107 references it cites were found in a registry or an index.
Abstract
Background: Heavy menstrual bleeding (HMB) is a common problem, yet evidence to inform decisions about initial medical treatment is limited. Objectives: To assess the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) (Mirena ® , Bayer) compared with usual medical treatment, with exploration of women’s perspectives on treatment. Design: A pragmatic, multicentre randomised trial with an economic evaluation and a longitudinal qualitative study. Setting: Women who presented in primary care. Participants: A total of 571 women with HMB. A purposeful sample of 27 women who were randomised or ineligible owing to treatment preference participated in semistructured face-to-face interviews around 2 and 12 months after commencing treatment. Interventions: LNG-IUS or usual medical treatment (tranexamic acid, mefenamic acid, combined oestrogen–progestogen or progesterone alone). Women could subsequently swap or cease their allocated treatment. Outcome measures: The primary outcome was the patient-reported score on the Menorrhagia Multi-Attribute Scale (MMAS) assessed over a 2-year period and then again at 5 years. Secondary outcomes included general quality of life (QoL), sexual activity, surgical intervention and safety. Data were analysed using iterative constant comparison. A state transition model-based cost–utility analysis was undertaken alongside the randomised trial. Quality-adjusted life-years (QALYs) were derived from the European Quality of Life-5 Dimensions (EQ-5D) and the Short Form questionnaire-6 Dimensions (SF-6D). The intention-to-treat analyses were reported as cost per QALY gained. Uncertainty was explored by conducting both deterministic and probabilistic sensitivity analyses. Results: The MMAS total scores improved significantly in both groups at all time points, but were significantly greater for the LNG-IUS than for usual treatment [mean difference over 2 years was 13.4 points, 95% confidence interval (CI) 9.9 to 16.9 points; p < 0.001]. However, this difference between groups was reduced and no longer significant by 5 years (mean difference in scores 3.9 points, 95% CI –0.6 to 8.3 points; p = 0.09). By 5 years, only 47% of women had a LNG-IUS in place and 15% were still taking usual medical treatment. Five-year surgery rates were low, at 20%, and were similar, irrespective of initial treatments. There were no significant differences in serious adverse events between groups. Using the EQ-5D, at 2 years, the relative cost-effectiveness of the LNG-IUS compared with usual medical treatment was £1600 per QALY, which by 5 years was reduced to £114 per QALY. Using the SF-6D, usual medical treatment dominates the LNG-IUS. The qualitative findings show that women’s experiences and expectations of medical treatments for HMB vary considerably and change over time. Women had high expectations of a prompt effect from medical treatments. Conclusions: The LNG-IUS, compared with usual medical therapies, resulted in greater improvement over 2 years in women’s assessments of the effect of HMB on their daily routine, including work, social and family life, and psychological and physical well-being. At 5 years, the differences were no longer significant. A similar low proportion of women required surgical intervention in both groups. The LNG-IUS is cost-effective in both the short and medium term, using the method generally recommended by the National Institute for Health and Care Excellence. Using the alternative measures to value QoL will have a considerable impact on cost-effectiveness decisions. It will be important to explore the clinical and health-care trajectories of the ECLIPSE (clinical effectiveness and cost-effectiveness of levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia) trial participants to 10 years, by which time half of the cohort will have reached menopause. Trial registration: Current Controlled Trials ISRCTN86566246. Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 19, No. 88. See the NIHR Journals Library website for further project information
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When this health benefit is valued in monetary terms at the UK Department of Health's current rate of £60 000 per QALY,24 this represents a ROI of 3.16 (£60 000−£13 000/£13 000).”
From Return on investment of public health interventions: a systematic review (2017) · cites this paper as [23]
In the citing paper
“It has been estimated that investing an additional £13 000 in the English National Health Service (NHS) can achieve health benefits of one additional quality-adjusted life year (QALY).23”
From Return on investment of public health interventions: a systematic review (2017) · cites this paper as [23]
In the citing paper
“many trials struggle with recruitment and often request extensions or become at risk of closure. 14 15”
From Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study (2018) · cites this paper as [14]
In the citing paper
“The mean cost of clinical trials funded by the UK National Institute for Health and Care Research was lower but still sizeable at about £1.3m, and also with considerable variation.104”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [104]
Citations
Cites
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Grounded theory research: Procedures, canons, and evaluative criteria
Corbin, J. M., & Strauss, A. (1990) · Qualitative Sociology · doi:10.1007/bf00988593 · Cited by 11,133
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700 · cited 2×
“5 SD, which is the minimum clinically important difference identified in a systematic review of studies reporting such data for health-related QoL measures.(79) A 13.”
BackgroundScale Development: Theory and Applications.
Xie, Y., & DeVellis, R. F. (1992) · Contemporary Sociology · doi:10.2307/2075704 · Cited by 3,635 · cited 1×
“9, suggesting that the items are all measuring aspects of the same construct.(68) Evidence of the homogeneity of the MMAS was also provided by the item total correlations (the correlation between each item and the total score minus that item) which range between 0.”
BackgroundDecision Modelling For Health Economic Evaluation
Briggs, A., Claxton, K., & Sculpher, M. (2006) · doi:10.1093/oso/9780198526629.001.0001 · Cited by 3,153
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?
Garratt, A. M., Ruta, D. A., Abdalla, M. I., Buckingham, J. K., & Russell, I. T. (1993) · BMJ · doi:10.1136/bmj.306.6890.1440 · Cited by 1,141
Strategy for intention to treat analysis in randomised trials with missing outcome data
White, I. R., Horton, N. J., Carpenter, J., statistics, R. I. M. A. S., & Pocock, S. J. (2011) · BMJ · doi:10.1136/bmj.d40 · Cited by 849 · cited 1×
“A number of sensitivity analyses were performed on the primary outcome to test the robustness of the results.(77,78) Analyses were performed excluding data received subsequent to a crossover to the alternative treatment group and also once study treatment was ceased altogether.”
MethodLinear mixed models for longitudinal data
(2000) · Springer Series in Statistics · doi:10.1007/b98969 · Cited by 818
A comparison of the EQ‐5D and SF‐6D across seven patient groups
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004) · Health Economics · doi:10.1002/hec.866 · Cited by 797 · cited 1×
“However, at the inception of this trial in 2002, the use of SF-6D was in its infancy and still being developed.(101) It was included in the current study as a methodological component.”
Method
Research works printed but not linked: 12
- National Institute for Health and Care Excellence, 2007, Heavy Menstrual Bleeding: Guideline CG44
- Royal College of Obstetrics and Gynaecology (RCOG), 1998, The Initial Management of Menorrhagia – Evidence-Based Clinical Guidelines No. 1
- Joint Formulary Committee, 2011, British National Formulary
- Gheit, 2009, Bleeding patterns associated with progestin-only contraceptives: a prospective controlled trial comparing Mirena versus progestin only pill, Middle East Fertil Soc J, 14, 216
- Kari, 2005, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of Mirena to a Three-Month Administration of Danazol Followed by a 3-Month Observation Period in Women Aged over 30 with Functional Menorrhagia
- Muenzen, 2009, A multicenter, randomized, open label, parallel group, active control study to evaluate the efficacy and safety of LNG IUS (Mirena) as compared to medroxyprogesterone acetate during 6 cycles of treatment in patients with idiopathic menorrhagia, BSP Report
- National Institute for Health and Care Excellence, 2013, Guide to the Methods of Technology Appraisal
- Cohen, 1977, Statistical Power Analysis for the Behavioural Sciences
- Shaw, 2007, Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia, Aust N Z J Obstet Gynaecol, 47, 335, 10.1111/j.1479-828X.2007.00747.x · DOI
- Belevantsev, Model of transition from anodization to microarc stage, Izv Sib Otd an Khim, 6, 73
- Curtis, 2012, Unit Costs of Health and Social Care 2011
- National Institute for Health and Care Excellence, 2008, Guide to the Methods of Technology Appraisal
Cited by
Items 301–395 of 395
Frisk, B., Sundør, I. E., Dønåsen, M. R., Refvem, O. K., & Borge, C. R. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-053503 · Cited by 4
Agarwal, M., Singh, S., Sinha, S., & Sinha, H. H. (2023) · Cureus · doi:10.7759/cureus.36142 · Cited by 4
“In our study, all domains of the MMAS and MOS SF-36 improved with LNG-IUS such as in the Effectiveness and Cost-Effectiveness of Levonorgestrel-Containing Intrauterine System in Primary Care Against Standard Treatment for Menorrhagia (ECLIPSE) trial [5].”
BackgroundMethodArnold, S., Spalding, T., Parsons, H. M., Beard, D. J., Bradley, H., Crisford, P., Ellard, D. R., Ferreira, M., Getgood, A. M. J., Guck, J., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-085125 · Cited by 4
Should we integrate viscoelastic assays with standard coagulation screening?
Visweshwar, N., Jaglal, M. V., Patel, A., Laber, D., & Sokol, L. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-207099 · Cited by 3
Cai, S., Aris, I. M., Yuan, W. L., Tan, K. H., Godfrey, K. M., Gluckman, P. D., Shek, L. P., Chong, Y. S., Yap, F. K. P., Fortier, M. V., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001396 · Cited by 6
O’Rinn, S., Barrett, J. F. R., Parsons, J. A., Kingdom, J. C., & D'Souza, R. D. (2023) · BMJ Open · doi:10.1136/bmjopen-2021-060699 · Cited by 5
Gallant, A. J., Steenbeek, A., Halperin, S. A., Leigh, J. P., & Curran, J. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073172 · Cited by 4
Wu, L., Gao, L., Zhao, X., Zhang, M., Wu, J., & Mi, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016241 · Cited by 4
Simpson, J., Javanbakht, M., & Vale, L. D. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030678 · Cited by 5
Knowledge of Latin American Obstetricians and Gynecologists regarding Heavy Menstrual Bleeding
Bahamondes, L. G., Marin, V., Ciarmatori, S., Filho, A. L. D. S., Acuna, J. M., & Makuch, M. Y. (2016) · Obstetrics and Gynecology International · doi:10.1155/2016/6870679 · Cited by 4
“…relief of bleeding in women with HMB, although some of them (between one quarter and one-third) reported higher possibility of improvement of HMB using a COC with estradiol valerate and dienogest (E 2 Val/DNG) or with the placement of a levonorgestrel-releasing intrauterine system (LNG-IUS).”
BackgroundFerguson, A., Newham, R., Dunlop, E., Preston, K., & Bennie, M. (2025) · BMJ Open Quality · doi:10.1136/bmjoq-2024-003023 · Cited by 3
Gismero-Moreno, S., Sánchez, F. J., Soler, N. G., Rivas‐Ruiz, F., & Ruíz, A. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103539 · Cited by 4
A Review on Menorrhagia: Investigation, Miracle Role of Herbs and Medical Treatment
Das, M. S. (2020) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2020.7020 · Cited by 3
van der Sluijs, P. J., Pour, K. S., Berends, C. L., Kruizinga, M. D., Müller, A. R., van Eeghen, A. M., Rodríguez‐Girondo, M., Juachon, M. J., Steenbeek, D., Cohen, A. F., et al. (2024) · Journal of Medical Genetics · doi:10.1136/jmg-2024-109951 · Cited by 3
Vanicek, N., Coleman, E., Watson, J. M., Bell, K. J., McDaid, C., Barnett, C. T., Twiste, M., Jepson, F., Salawu, A., Harrison, D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045195 · Cited by 3
Real-world outcomes of a clinical decision support system for diabetic retinopathy in Spain
Romero‐Aroca, P., Verges, R., Maaroof, N., Mateu, A. V., Latorre, A., Moreno, A., Sagarra-Alamo, R., Basora, J., Cristiano, J., & Baget‐Bernaldiz, M. (2022) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2022-000974 · Cited by 5
Dhanda, A., Allende, H., Allgar, V. L., Andrade, J., Bailey, M. P., Callaghan, L., Cocking, L., Goodwin, E., Hawton, A., Hayward, C. J., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060498 · Cited by 3
Zhu, D., Mahmud, A. A., & Liu, W. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078188 · Cited by 3
Prevention of hospital-acquired thrombosis from a primary care perspective: a qualitative study
Litchfield, I. J., Fitzmaurice, D. A., Apenteng, P. N., Harrison, S., Heneghan, C. J., Ward, A. M., & Greenfield, S. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x685693 · Cited by 4
Bennett, A., Thavorn, K., Arendas, K., Coyle, D., & Singh, S. S. (2020) · CMAJ Open · doi:10.9778/cmajo.20190170 · Cited by 3
Kellerer, C., Hapfelmeier, A., Jörres, R. A., Schultz, K., Brunn, B., & Schneider, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045420 · Cited by 5
Arthroscopic and open repair of massive rotator cuff tears have similar results: a systematic review
Sevivas, N., Ferreira, N., Andrade, R., Moreira, P. S., Sousa, N., Salgado, A. J., & Espregueira‐Mendes, J. (2017) · Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine · doi:10.1136/jisakos-2017-000124 · Cited by 3
Kern, D., Ljótsson, B., Lönndahl, L., Hedman‐Lagerlöf, E., Bradley, M., Lindefors, N., & Kraepelien, M. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068908 · Cited by 3
The race for higher sensitivity troponins, but for what prize?
Gale, C. P., & Bueno, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw200 · Cited by 3
Screen and intervene to prevent diabetes?
Waugh, N. R. (2017) · BMJ · doi:10.1136/bmj.i6800 · Cited by 3
Patient-facing online triage tools and clinician decision-making: a systematic review
Paule, A., Abel, G., Parsons, J., & Atherton, H. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094068 · Cited by 6
Birch, J. M., Mueller, J., Damery, S. L., Sharp, S. J., Jones, R. A. P., Kelly, M. P., Anderson, A. S., Astbury, N. M., Aveyard, P. N., Beeken, R. J., et al. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-001382 · Cited by 3
Childs, M. J., Aldridge, S. J., Daniels, H., Davies, G. I., Best, V., Abbasizanjani, H., Lyons, R. A., Akbari, A., & Torabi, F. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103724 · Cited by 2
Sribnick, E. A., Wenger, N., Nicol, K. K., & Tobias, J. D. (2020) · BMJ Case Reports · doi:10.1136/bcr-2020-236608 · Cited by 2
Haider, S., Adderley, N. J., Tallouzi, M., Sadiq, S. N., STEEL, D. H., Chavan, R., Sheikh, I., Nirantharakumar, K., & Snell, K. I. E. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073015 · Cited by 3
Leese, C. J., Mann, R. H., Cockcroft, E., & Abraham, K. (2023) · BJGP Open · doi:10.3399/bjgpo.2023.0051 · Cited by 2
Dhanda, A., Andrade, J., Allende, H., Allgar, V. L., Bailey, M. P., Callaghan, L., Cocking, L., Goodwin, E., Hawton, A., Hayward, C. J., et al. (2024) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2023-001267 · Cited by 4
Klamroth, S., Mino, E., Naber, I., Weißenfels, A., Geidl, W., Gelius, P. C., Abu‐Omar, K., & Pfeifer, K. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082710 · Cited by 5
Timing of Stoma Closure in Neonates: the ToSCiN mixed-methods study
Lansdale, N., Woolfall, K., Deja, E., Mitchell, T. K., Singhal, G., Goldacre, R., Ramakrishnan, R., Hall, N. J., Battersby, C., Gale, C., et al. (2024) · Health Technology Assessment · doi:10.3310/jfbc1893 · Cited by 4
Economic effects of priority setting in healthcare: a scoping review of current evidence
Leskelä, R., Vanhala, A., Gehrmann, K., Haapatalo, E., Ranta, J., Patja, K., Kousa, I., Tapanainen, P., Pantzar, M., Tikkinen, K. A. O., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-086342 · Cited by 4
Haines, J., Butler, J., Smith, J. A., Fowler, S. J., & Yorke, J. (2025) · ERJ Open Research · doi:10.1183/23120541.00336-2025 · Cited by 3
Tesfaye, L., Wakeman, M., Baskin, G., Gregory, T., Gruse, G., Leahy, E., Kendrick, B., & El‐Toukhy, S. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-002354 · Cited by 3
Schilder, A. G., & Venekamp, R. P. (2016) · Evidence-Based Nursing · doi:10.1136/eb-2015-102268 · Cited by 2
Impact of missed treatment opportunities on outcomes in hospitalised patients with heart failure
Walker, S., Spackman, E., Conrad, N., Emdin, C. A., Griffin, E., Rahimi, K., & Sculpher, M. J. (2017) · Open Heart · doi:10.1136/openhrt-2017-000726 · Cited by 2
Laughton, M., Patel, N., Dawoodbhoy, F. M., ghrably, S. E., Frater, J., & Mahmud, S. (2021) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2021.102229 · Cited by 2
Agostinho, S. C. D. A., Tavares, A. B., & Tavares, R. F. N. (2020) · Comunicação em Ciências da Saúde · doi:10.51723/ccs.v31i02.573 · Cited by 2
Concerns about the evidence in relation to implementation of the ProFHER trial
Handoll, H. H., Brealey, S., & Rangan, A. (2020) · BMJ Quality & Safety · doi:10.1136/bmjqs-2020-010854 · Cited by 2
Lensen, S. F., Macnair, A., Love, S., Yorke-Edwards, V., Noor, N. M., Martyn, M., Blenkinsop, A., Díaz-Montaña, C., Powell, G. A., Williamson, E., et al. (2020) · medRxiv · doi:10.1101/2020.04.08.20033373 · Cited by 2
Biggs, K., Thomas, B., Goodacre, S. W., Lee, E. C., Sutton, L., Bursnall, M., Loban, A., Waterhouse, S., Simmonds, R., Marincowitz, C., et al. (2020) · medRxiv · doi:10.1101/2020.09.01.20185793 · Cited by 2
Evaluation of fractional exhaled nitric oxide measurement in defence primary healthcare
Willman, A. S., Howard-Harwood, B., & Blackadder-Weinstein, J. (2024) · BMJ Military Health · doi:10.1136/military-2024-002675 · Cited by 1
Counseling Women About Sexual Health Effects of Contraceptives
Vegunta, S., Houston, L. E., Nicholson, N. A., & David, P. S. (2024) · Journal of Women s Health · doi:10.1089/jwh.2023.0625 · Cited by 3
Cowie, J., Findlay, S. D., Archibald, R., Currie, S., Campbell, P., Hutcheon, D., Pol, M. M. V. D., MacLennan, G., Cook, E. L., Lock, B., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-092908 · Cited by 2
Labree, B., Hoare, D. J., Fackrell, K., Hall, D. A., Gascoyne, L. E., & Sereda, M. (2025) · BMJ Open · doi:10.1136/bmjopen-2023-079769 · Cited by 1
Elwenspoek, M. M. C., O’Donnell, R., Jackson, J., Dawson, S., Charlwood, K., Hay, A. D., Watson, J., & Whiting, P. F. (2025) · British Journal of General Practice · doi:10.3399/bjgp.2024.0744 · Cited by 2
Valuing health across groups: a cross-sectional population-based willingness-to-pay survey in Bhutan
Yao, Y. X., Rahman, M., Pempa, P., Teerawattananon, Y., & Nakamura, R. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2025-019098 · Cited by 2
Jerez‐Roig, J., Aguila-Gimeno, O., Brazaitis, M., Solianik, R., Karkauskienė, E., Jarutienė, L., Fuente-Vidal, A., Borralleras-Fumaña, E., Gasteiger, N., & Stanmore, E. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-100487 · Cited by 1
Pirouzmand, F., Mathieu, F., Mansouri, A., Kavikondala, K., Alkins, R. D., Boyd, J. G., Christie, S., Couillard, P. L., Cusimano, M. D., Engels, P. T., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-114158 · Cited by 1
Abnormal Vaginal Bleeding During the Early Reproductive Years
Nelson, A. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-17002-2_23-1 · Cited by 1
Cook, A., Streit, E., & Davage, G. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016104 · Cited by 1
Hanson, C. L., McHale, S., Neubeck, L., Dougall, N. J., & Kelly, P. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-089723 · Cited by 1
Morris, J. H., Irvine, L. A., Breckenridge, J. P., Farré, A., Özakinci, G., Jenkinson, K., Murphy, A., & Dombrowski, S. U. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093838 · Cited by 1
Kitic, C. M., Selig, S., Davison, K., Best, T., Parmenter, B. J., Pumpa, K. L., Furzer, B. J., Rice, V., Hardcastle, S., Cheney, M., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027610 · Cited by 1
Pierami, R., Antonioli, E., Oliveira, I., Castro, I. Q., Manente, F. G., Fairbanks, P. J., Carrera, E. D. F., Matsumura, B. A., & Lenza, M. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-043126 · Cited by 1
Intrauterine devices for menorrhagia
Potter, J., & Lindblad, A. J. (2023) · Canadian Family Physician · doi:10.46747/cfp.6902113 · Cited by 1
Contrast Ultrasound Ischemic Memory Imaging
Leong-Poi, H. M. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2015.12.021 · Cited by 1
Supporting smokers’ quit attempts reduces national smoking prevalence
Coleman, T. J. (2019) · Thorax · doi:10.1136/thoraxjnl-2019-213265 · Cited by 1
Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)Preprint
Bath, P. M., Ball, J. K., Boyd, M., Gage, H., Glover, M. J., Godfrey, M., Guthrie, B., Hewitt, J., Howard, R. J., Jaki, T., et al. (2022) · medRxiv · doi:10.1101/2022.08.29.22279359 · Cited by 1
Burton, R. J., Raffray, L., Moet, L., Cuff, S. M., White, D. A., Baker, S. E., Moser, B., O’Donnell, V. B., Ghazal, P., Morgan, M. P. G., et al. (2023) · medRxiv · doi:10.1101/2023.09.13.23295490 · Cited by 1
Gilbody, S. M. (2024) · medRxiv · doi:10.1101/2024.06.03.24308386 · Cited by 1
Oxytocin Enhances Social-Emotional Reciprocity in AutismPreprint
Strobl, E. V. (2025) · medRxiv · doi:10.1101/2025.07.20.25331870 · Cited by 1
Intermittent pneumatic compression is effective in reducing proximal DVT
Ho, K. M., & Harahsheh, Y. (2015) · Evidence-Based Nursing · doi:10.1136/eb-2015-102265
Effects of hormonal contraceptives on physical performance and body composition
Myllyaho, M. M. (2016) · Jyväskylä University Digital Archive (University of Jyväskylä)
A woman, age 35, with new-onset ascites
Lippert, W. C., Lee, E. Y., & Mirrakhimov, A. E. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86a.17082
Abnorme uterine Blutungen in der Peri- und Postmenopause
Segerer, S. E. (2019) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-019-0088-y
Trop tôt ou trop tard? Choisir le bon intervalle pour les tests de dépistage
Dickinson, J. A., Thériault, G., Singh, H., Grad, R. M., Bell, N. R., & Szafran, O. (2021) · Canadian Family Physician · doi:10.46747/cfp.6702e48 · Cited by 2
Huang, W., Karthik, G., Chua, T., & Graves, N. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-050553
Abnormal Vaginal Bleeding During the Early Reproductive Years
Nelson, A. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_23
How can GPs get people moving more?
Leung, R., Marino, K. R., Whittaker, D., Izquierdo, D., & Gopal, D. P. (2022) · British Journal of General Practice · doi:10.3399/bjgp22x719753
Valuable insights into caring for women with heavy menstrual bleeding
(2023) · Research outreach · doi:10.32907/ro-135-4236945013
Diagnostic Pathways of Postmenopausal Bleeding
Bouzouki, A., & Ewies, A. A. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-36179-1_15
Whitaker, L. H. R., Middleton, L. J., Priest, L., Odedra, S., Cheed, V., Nicholls, E. P., Williams, A. R. W., Roberts, N., Stubbs, C., Tryposkiadis, K., et al. (2023) · Efficacy and Mechanism Evaluation · doi:10.3310/fglq1687 · Cited by 2
Self-citationChing, J., Duff, S., & Hernandez, J. (2024) · medRxiv · doi:10.1101/2024.06.05.24306788 · Cited by 1
Qin, N., Luo, Y., Wang, S., Li, Y., Li, J., Luo, J., Zhou, J., Zhang, Q., Xie, J., & Cheng, A. S. K. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-086489 · Cited by 1
McGowan, R. A., Brown, H. S., López-Alvarenga, J. C., & Restrepo, B. I. (2024) · BMJ Public Health · doi:10.1136/bmjph-2024-001189
Goergen, A., Borsigova, M., Wueest, S., & Konrad, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.15.633246
New UK asthma guideline: meeting the challenge to change
Wang, K., Ryott, G., & Kurukulaaratchy, R. J. (2025) · BMJ · doi:10.1136/bmj.r262
Grezda, K., Audigé, L., Baum, C., Müller, S. A., Stojanov, T., Schwappach, D. L. B., Durchholz, H., ARCR_Pred Study Group, & Mueller, A. (2025) · BMJ Surgery Interventions & Health Technologies · doi:10.1136/bmjsit-2025-000400 · Cited by 4
Schoonakker, M. P., van den Burg, E. L., Sturm, C. A., Lamb, H. J., Pijl, H., Numans, M. E., Adriaanse, M. A., & van Peet, P. G. (2026) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2026.100730
Wright, D. M., Chakravarthy, U., Das, R., Graham, K. W., Naskas, T. T., Pető, T., & Hogg, R. E. (2026) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2025-002536
Predictive Factors for Traumatic Intraparenchymal Hemorrhage Expansion and Its Clinical Outcomes
Gad, M., Tafazolimoghadam, A., Zandieh, G., Kakadiya, J., Radmard, M., Chanmugam, A. S., Yousem, D. M., & Azzi, C. (2026) · American Journal of Neuroradiology · doi:10.3174/ajnr.a9244
Craemer, M. D., Kinaupenne, M., Decraene, M., Bogaert, L., & Willems, I. (2026) · medRxiv · doi:10.64898/2026.03.24.26349179 · Cited by 1
Novel approach to the codesign of a tailored intervention bundle: applying theory with pragmatism
Pokharel, S., Omodon, O., Woodhouse, D., Ferrie, L., Duncan, D., Mehta, A., & Ambasta, A. (2026) · BMJ Open Quality · doi:10.1136/bmjoq-2025-003861
How can a heavy menstrual bleeding scoring system be utilized in practice?
Al‐Inizi, S. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20262085
Küçükyurt, A. K., Kolcu, S. A., Ozturk, B., Kara, E., & Ilhan, G. K. (2026) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-026-02416-5
Molder, L. P. W. T., Sedelaar, J. P. M., Bomers, J. G. R., Boomsma, M. F., de Haan, T. D., van Melick, H. H. E., Meijerink, M. R., Beerlage, H. P., van Aubel, O., Collette, E. R. P., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-117276
Salgado, R., Amiguet, M., Costa, P., Delmas, P., & Padilha, J. M. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-116719
Ayurvedic Management of Endometrial Hyperplasia in Perimenopausal Women: Case Report
Rajpurohit, S., Pandya, N., Baraiya, H. P., & Solanki, G. (2026) · Journal of Ayurveda and Integrated Medical Sciences · doi:10.21760/jaims.11.7.70
Yang, Y., Green, K. L., Zhang, N., McGarrigle, L., & Todd, C. J. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-117339
Health, N. P. R. U. I. R., Proffitt, E., Dhar, D., Harvey-Pescott, L., Brown, E., McNiven, A., Felix, A., Lima, E. D., Rahman, Y., Bailey, J., et al. (2026) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2026-203239
Metadata
- Authors
- Gupta, J. K., Daniels, J. P., Middleton, L. J., Pattison, H. M., Prileszky, G., Roberts, T. E., Sanghera, S., Barton, P., Gray, R., Kai, J., & on behalf of the ECLIPSE Collaborative Group
- Affiliations
- Birmingham Women's Hospital (GB)
- University of Birmingham (GB)
- Aston University (GB)
- University of Nottingham (GB)
- University of Oxford (GB)
- Corresponding author
- Daniels, Jane P
- ORCID
- Venue
- Health Technology Assessment
- Published
- 2015-10
- Volume
- 19
- Issue
- 88
- Pages
- 1-118
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- PMC
- PMC4781345
- OpenAlex
- W2152498789
- Cited by
- 399
- References
- 107
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 25 · 2023: 28 · 2022: 32 · 2021: 53 · 2020: 50 · 2019: 44 · 2018: 48 · 2017: 49 · 2016: 28 · 2015: 3
- FWCI
- 45.25
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (publishedVersion, other-oa)
- Explore Bristol Research (publishedVersion)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Nottingham ePrints (University of Nottingham) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Health Technology Assessment programme (02/06/02)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- levonorgestrel-releasing intrauterine system, menorrhagia, primary care, cost-effectiveness, quality of life, patient-reported outcomes, tranexamic acid, mefenamic acid
- MeSH terms
- Antifibrinolytic Agents, Contraceptive Agents, Female, Cost-Benefit Analysis, Female, Humans, Intrauterine Devices, Medicated, Menorrhagia, Primary Health Care, Surveys and Questionnaires, Technology Assessment, Biomedical, Tranexamic Acid, Treatment Outcome, Levonorgestrel, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.